To explore the clinical effect of different inhaled drugs on patients with moderate or severe chronic obstructive pulmonary disease (COPD) in stable phase.
180 patients with moderate or severe stable COPD treated in our hospital from July 2020 to July 2022 were randomly divided into three groups: A group, B group and C group, and 60 cases in each group. The patients in A group were given tiotropium bromide, the patients in B group were given salmeterol/ticasone, and the patients in C group were treated with umeclidinium bromide/vilanterol trifenatate. Pulmonary function index, blood gas index, level of inflammatory factors and adverse events during intervention were compared before and after treatment among the three groups.
After intervention, the clinical effective rate of A, B and C group increased successively, and the differences were statistically significant (P<0.05). The levels of forced expiratory volume in one second (FEV1), FEV1% pred and FEV1/forced vital capacity (FVC) in group C were significantly higher than those in A and B group (P<0.05), but there was no significant difference in the level of peak expiratory flow (PEF) among the three groups (P>0.05). The levels of PaO2 and SaO2 in group C were significantly higher than those in A and B group (P<0.05), while the level of PaCO2 in C group was significantly lower than that in A and B group (P<0.05). The levels of IL-6, IL-8 and TNF-α in C group were similar to those in B group (P>0.05) and significantly lower than those in A group (P<0.05). During the intervention period, the number of acute attacks in C group was significantly lower than that in A and B group (P<0.05), but there was no significant difference in adverse events among the three groups (P>0.05).
Umeclidinium bromide/vilanterol trifenatate can effectively improve pulmonary function and blood gas indexes, reduce inflammatory reaction, reduce the risk of acute attack in patients with moderate or severe stable COPD, with good safety.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |